voriconazole and Keratosis, Actinic
voriconazole has been researched along with Keratosis, Actinic in 4 studies
Research
Studies (4)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Asahina, A; Nobeyama, Y; Umezawa, Y | 1 |
Bellodi Schmidt, F; Lalor, LE; Li, AW; Luu, M | 1 |
Asahina, A; Itoh, M; Kikuchi, S; Matsuo, H; Mizuno, S | 1 |
Kong, DC; Kotsimbos, T; Levvey, B; Morrissey, O; Neoh, CF; Slavin, MA; Snell, GI; Stewart, K | 1 |
Other Studies
4 other study(ies) available for voriconazole and Keratosis, Actinic
Article | Year |
---|---|
Risk of squamous cell carcinoma in immunosuppressed patients with voriconazole-related actinic keratosis.
Topics: Adult; Aged; Carcinoma, Squamous Cell; Disease Progression; Humans; Immunosuppressive Agents; Keratosis, Actinic; Middle Aged; Retrospective Studies; Skin Neoplasms; Voriconazole | 2022 |
A pediatric case of squamous cell cancer in situ in the setting of sclerodermatous graft-versus-host disease and voriconazole treatment.
Topics: Administration, Topical; Antifungal Agents; Bone Marrow Transplantation; Carcinoma, Squamous Cell; Dermatitis, Phototoxic; Fluorouracil; Graft vs Host Disease; Humans; Immunosuppressive Agents; Keratosis, Actinic; Male; Skin; Skin Neoplasms; Voriconazole | 2018 |
Case of ultraviolet B-mediated photosensitivity during the administration of voriconazole.
Topics: Aged; Antifungal Agents; Aspergillosis; Humans; Keratosis, Actinic; Male; Paranasal Sinus Diseases; Photosensitivity Disorders; Skin; Skin Tests; Ultraviolet Rays; Voriconazole | 2019 |
Lung transplant recipients receiving voriconazole and skin squamous cell carcinoma risk in Australia.
Topics: Antifungal Agents; Aspergillosis; Australia; Bronchitis; Carcinoma, Squamous Cell; Female; Humans; Keratosis, Actinic; Lung Transplantation; Middle Aged; Skin Neoplasms; Tracheitis; Transplant Recipients; Voriconazole | 2014 |